Emma Yasinski

Langer-inspired Kala files for an $86M IPO; J&J backs Provention Bio

8 years ago

News Briefing

OvaScience and Active Biotech name new CEOs, Valeant adds John Paulson to the board

8 years ago

Peer Review

Merck KGaA gets a thumbs up for once-dead MS drug; Aveo shares soar as tivo makes a comeback

8 years ago

News Briefing

Patrick Soon-Shiong accused of more conflicts of interest; Eli Lilly expands in San Diego

8 years ago

News Briefing

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment

8 years ago

News Briefing

In wake of a trial disaster, Seattle Genetics files sBLA; Egalet takes a dive on a CRL

8 years ago

News Briefing

Novartis chief says Trump visa restrictions sour US hiring plans; Parexel and Sanofi to develop wearable devices

8 years ago

News Briefing

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

8 years ago

Peer Review

Loxo raising $227M in post-ASCO score; Bavarian Nordic reports data delay; Sonar and Stratus ordered to cease ...

8 years ago

News Briefing

Alexandria LaunchLabs opens, J&J announces more collaborations

8 years ago

News Briefing

Researchers develop a small-molecule 'sunless tan' to guard against skin cancer

8 years ago

Discovery

Orum takes $8M in Series A; Twist bags $27M in venture financing

8 years ago

News Briefing

Abbvie, Principia join forces on immunoproteasome inhibitors; Scripps develops heroin vaccine, FDA fast tracks NGF ...

8 years ago

News Briefing

Harvard researchers hope to bridge the protein gap with new institute

8 years ago

R&D

Discovery

Seres grabs $20M on PhIII microbiome launch; Gilead submits NDA; Alkermes begins Phase IIIb study

8 years ago

News Briefing

Peer Review: J&J woos Merck’s Mathai Mammen to helm of pharma R&D; Merrimack, Bayer, and Axovant expand leadership ...

8 years ago

Peer Review

Bristol-Myers shares drop; Regenera offers a lifeline to sinking Alcobra

8 years ago

News Briefing

Analysts project a big spike in COPD market as new drugs arrive; Valeant raises $930M in latest asset sale

8 years ago

News Briefing

AstraZeneca raises $200M from its latest asset sale; Austin-based Lung Therapeutics raises $14M in venture cash

8 years ago

News Briefing

WuXi Biologics IPO reaps $509M windfall; Intellia strikes CRISPR pact with San Raffaele

8 years ago

News Briefing

Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122

8 years ago

News Briefing

Eli Lilly's CFO retiring after 27 years at company; Alexion names a new slate of execs

8 years ago

Peer Review

Ben-Gurion University seeking partner to repurpose old lymphoma drug to treat ALS

8 years ago

Discovery

Deciphera banks a $52M C round for cancer R&D; Ionis adds $50M milestone from Biogen

8 years ago

News Briefing

about the author

author articles

Langer-inspired Kala files for an $86M IPO; J&J backs Provention Bio

OvaScience and Active Biotech name new CEOs, Valeant adds John Paulson to the board

Merck KGaA gets a thumbs up for once-dead MS drug; Aveo shares soar as tivo makes a comeback

Patrick Soon-Shiong accused of more conflicts of interest; Eli Lilly expands in San Diego

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment

In wake of a trial disaster, Seattle Genetics files sBLA; Egalet takes a dive on a CRL

Novartis chief says Trump visa restrictions sour US hiring plans; Parexel and Sanofi to develop wearable devices

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

Loxo raising $227M in post-ASCO score; Bavarian Nordic reports data delay; Sonar and Stratus ordered to cease ...

Alexandria LaunchLabs opens, J&J announces more collaborations

Researchers develop a small-molecule 'sunless tan' to guard against skin cancer

Orum takes $8M in Series A; Twist bags $27M in venture financing

Abbvie, Principia join forces on immunoproteasome inhibitors; Scripps develops heroin vaccine, FDA fast tracks NGF ...

Harvard researchers hope to bridge the protein gap with new institute

Seres grabs $20M on PhIII microbiome launch; Gilead submits NDA; Alkermes begins Phase IIIb study

Peer Review: J&J woos Merck’s Mathai Mammen to helm of pharma R&D; Merrimack, Bayer, and Axovant expand leadership ...

Bristol-Myers shares drop; Regenera offers a lifeline to sinking Alcobra

Analysts project a big spike in COPD market as new drugs arrive; Valeant raises $930M in latest asset sale

AstraZeneca raises $200M from its latest asset sale; Austin-based Lung Therapeutics raises $14M in venture cash

WuXi Biologics IPO reaps $509M windfall; Intellia strikes CRISPR pact with San Raffaele

Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122

Eli Lilly's CFO retiring after 27 years at company; Alexion names a new slate of execs

Ben-Gurion University seeking partner to repurpose old lymphoma drug to treat ALS

Deciphera banks a $52M C round for cancer R&D; Ionis adds $50M milestone from Biogen